TOXICON
Scope & Guideline
Advancing Toxicology Through Rigorous Research
Introduction
Aims and Scopes
- Toxin Mechanisms and Pathophysiology:
Research exploring the biochemical and molecular mechanisms of action of various toxins, including snake venoms, bacterial toxins, and mycotoxins, contributes to understanding their pathophysiological effects on human and animal health. - Clinical Toxicology and Management:
Studies on clinical presentations, management strategies, and therapeutic interventions for toxin exposure, including snakebites and poisoning incidents, help improve patient outcomes and inform clinical practices. - Toxinology and Venom Research:
Focus on the characterization of venom components from various species, including snakes, spiders, and other venomous organisms, to elucidate their pharmacological properties and potential therapeutic applications. - Environmental and Food Toxicology:
Research that addresses the impact of environmental toxins, including mycotoxins, on human health and food safety, aiming to develop mitigation strategies and enhance public health. - Innovative Therapeutics and Antivenoms:
Exploration of novel therapeutic agents, including the development of antivenoms, small molecule inhibitors, and natural products that counteract the effects of toxins.
Trending and Emerging
- Molecular and Genetic Characterization:
There is an increasing trend towards the molecular and genetic characterization of toxins, including studies on the genomics of venomous species and the identification of specific toxin genes. - Mycotoxin Research and Food Safety:
Research on mycotoxins and their effects on food safety and public health is gaining prominence, particularly in relation to their prevalence in agricultural products and potential health impacts. - Neurotoxicology and Neurological Effects of Toxins:
Emerging studies are focusing on the neurotoxic effects of various venoms and toxins, exploring their impact on the nervous system and potential therapeutic applications. - Innovative Drug Development from Toxins:
There is a notable increase in research exploring the potential of toxins as leads for novel therapeutic agents, including anticancer drugs and antimicrobial peptides. - Environmental Impact of Toxins:
Research addressing the environmental consequences of toxins, including cyanotoxins and their effects on ecosystems, has become more prominent as ecological health becomes a priority.
Declining or Waning
- Traditional Antivenom Research:
There seems to be a waning interest in traditional antivenom research as newer methodologies, such as recombinant antivenoms and monoclonal antibodies, gain traction in the field. - General Toxicology Studies:
The journal appears to be shifting away from broad general toxicology studies that do not focus on specific toxins or mechanisms, favoring more targeted studies with clinical relevance. - Insect Venom Research:
Research specifically focused on insect venoms has decreased, possibly due to the increasing interest in more clinically relevant toxins from reptiles and mammals. - Historical Perspectives in Toxinology:
There has been a noticeable reduction in papers focusing on historical aspects of toxinology, as the field moves towards more contemporary and applied research.
Similar Journals
JOURNAL OF APPLIED TOXICOLOGY
Exploring the Impact of Chemicals on LifeJOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.
TOXICOLOGICAL SCIENCES
Exploring the Frontiers of Toxicology and Public HealthTOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.
Drug Research
Exploring New Horizons in Drug DiscoveryDrug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.
Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis
Advancing Knowledge on Toxicology and CarcinogenesisThe Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis is a vital publication in the fields of environmental science, toxicology, and cancer research, published by Taylor & Francis Inc. With an ISSN of 2689-6583 and E-ISSN 2689-6591, this journal provides a platform for peer-reviewed research that explores the intersection of environmental factors and health outcomes, particularly focusing on toxicological and carcinogenic impacts. Though it does not currently offer Open Access, it remains a significant contributor to academia with its current ranking in the Q4 category for Cancer Research and Q3 in Health, Toxicology and Mutagenesis. The journal has converged from 2020 to 2024 and aims to disseminate pioneering studies that inform public health policies and foster a deeper understanding of environmental toxins. Aspiring researchers, professionals, and students will find this journal to be an essential resource for the latest findings and discussions within these critical fields.
Toxins
Empowering the global community with vital toxicology research.Toxins, published by MDPI, is a leading open-access journal specializing in the field of toxicology, with a strong emphasis on the health implications of toxins across various environments. Established in 2009, this journal has quickly ascended to prominence, attaining a Q1 ranking in both the Health, Toxicology and Mutagenesis and Toxicology categories, underscoring its significant contribution to the scientific community. With an impressive Scopus ranking, placing it within the top percentile of related fields, Toxins serves as a vital resource for researchers, professionals, and students dedicated to advancing knowledge in toxicology and environmental health. The journal encourages the open dissemination of innovative research and critical reviews that explore the mechanisms, effects, and management of toxic substances, thus ensuring that vital research outcomes reach a global audience. For those looking to keep abreast of cutting-edge developments in the field, Toxins is an indispensable platform for scientific exchange and collaboration.
Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment
Transforming knowledge into safer food practices.Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment, published by Taylor & Francis Ltd, is a leading journal in the field of food science, toxicology, and public health. With an ISSN of 1944-0049 and an E-ISSN of 1944-0057, this esteemed publication has established itself as a vital resource for researchers and professionals involved in the analysis and regulation of food additives and contaminants. Since its inception and through its converged years from 2008 to 2012 and again from 2014 to 2023, the journal has maintained an impactful presence, notably achieving a Q2 ranking in diverse categories including Chemistry (miscellaneous) and Food Science, alongside commendable standings in Health and Environmental Health. The journal’s mission is to foster high-quality research by providing a platform for critical studies related to chemical analysis, exposure assessments, and risk management in food safety. By prioritizing engaging, peer-reviewed content, it aims to enhance understanding and mitigate risks associated with food additives, making it an indispensable tool for academics, practitioners, and policymakers alike.
TOXICOLOGY LETTERS
Connecting research and practice for a healthier world.TOXICOLOGY LETTERS is a prominent journal dedicated to advancing the field of toxicology, providing a platform for high-quality research and reviews that explore the effects of chemical substances on biological systems. Published by Elsevier Ireland Ltd, this peer-reviewed journal has established itself as a vital resource in toxicological research since its inception in 1977, with a convergence of studies extending to 2024. With an impressive Scopus ranking, positioned at #28 out of 133 in the Toxicology category, TOXICOLOGY LETTERS garners a respectable percentile of 79, highlighting its significance in the academic community. Although it is not an open-access journal, its research is accessible through institutional subscriptions, ensuring that critical insights into human health and environmental safety are disseminated effectively. Being categorized in the Q2 quartile in both Medicine (miscellaneous) and Toxicology for 2023 further emphasizes its relevance and impact in these fields. This journal aims to foster collaboration between researchers and professionals, encouraging the exploration of innovative solutions to chemical hazards and the promotion of safer practices in pharmacology and toxicology.
CRITICAL REVIEWS IN TOXICOLOGY
Exploring the Depths of Toxicology for a Safer FutureCRITICAL REVIEWS IN TOXICOLOGY, published by Taylor & Francis Ltd, stands as a preeminent journal within the field of toxicology, boasting an impressive Q1 ranking and holding the distinction of being ranked 12th out of 133 in the toxicology category according to Scopus, placing it in the top 91st percentile. With a continuous publication history since 1971 and a commitment to providing high-quality reviews, the journal offers critical insight into the latest research and advancements in toxicological sciences. While it is not an open-access journal, it provides numerous access options for both subscribers and institutions, ensuring that its extensive articles are widely available to the academic community. The journal's objectives are to disseminate comprehensive reviews that foster understanding and innovation in the assessment of chemical risks, environmental impacts, and the mechanisms of toxicity, making it an invaluable resource for researchers, professionals, and students dedicated to the science of toxicology.
DARU-Journal of Pharmaceutical Sciences
Innovating drug discovery through rigorous research.DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
Advancing the Frontiers of Toxicology and BiochemistryJournal of Biochemical and Molecular Toxicology, published by Wiley, plays a pivotal role in the advancement of knowledge within the fields of biochemistry, toxicology, and molecular biology. Established in 1998, this esteemed journal has garnered a significant reputation, evidenced by its current placement in the Q2 quartile across several categories, including Biochemistry, Health, Toxicology and Mutagenesis, and Medicine. With an ISSN of 1095-6670 and an E-ISSN of 1099-0461, it serves an international audience, offering critical insights and innovative research that shape our understanding of biochemical interactions and toxicological assessments. While it does not operate on an open-access model, the journal ensures rigorous peer review and high-quality publication standards, making it a valuable resource for researchers, professionals, and students dedicated to the exploration of molecular toxicology. The journal's recognized impact within the scientific community is reflected in its competitive rankings among specialized journals, fostering significant contributions to both academic and applied contexts.